Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Mallinckrodt
UBS
Cerilliant
Accenture
Federal Trade Commission
Farmers Insurance
Queensland Health
Boehringer Ingelheim

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020291

« Back to Dashboard

NDA 020291 describes COMBIVENT, which is a drug marketed by Boehringer Ingelheim and is included in two NDAs. There are eleven patents protecting this drug. Additional details are available on the COMBIVENT profile page.

The generic ingredient in COMBIVENT is albuterol sulfate; ipratropium bromide. There are thirty-eight drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the albuterol sulfate; ipratropium bromide profile page.
Summary for 020291
Tradename:COMBIVENT
Applicant:Boehringer Ingelheim
Ingredient:albuterol sulfate; ipratropium bromide
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:AEROSOL, METERED;INHALATIONStrengthEQ 0.09MG BASE/INH;0.018MG/INH
Approval Date:Oct 24, 1996TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Citi
McKesson
AstraZeneca
Queensland Health
Harvard Business School
Julphar
UBS
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.